메드라인(MDLN) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

MDLN

Medline Inc

7월 27일 12:57 PM ET (한국 7/28 01:57)

$38.75

+1.12 ▲ +2.98%

메드라인(MDLN) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$50.9B

미드캡

P/E

32.4

적정 수준

배당수익률

0.15%

52주 위치

33%

저점 +18% · 고점 -24%

애널리스트

매수

Fundamental health

vs. Medical Instruments & Supplies

수익성

Top 59%

성장

Top 83%

밸류에이션

Top 45%

재무 안정

Top 33%

Index ⓘ	-	P/E ⓘ	32.41	EPS (ttm) ⓘ	1.2	Insider Own ⓘ	36.14%	Shs Outstand ⓘ	846.0M	Perf Week ⓘ	-2.61%
Market Cap ⓘ	50.91B	Forward P/E ⓘ	23.38	EPS next Y ⓘ	9.41%	Insider Trans ⓘ	-37.5%	Shs Float ⓘ	540.0M	Perf Month ⓘ	7.49%
Enterprise Value ⓘ	69.38B	PEG ⓘ	2.53	EPS next Q ⓘ	0.32	Inst Own ⓘ	63.83%	Short Float ⓘ	6.72%	Perf Quarter ⓘ	-16.18%
Income ⓘ	0.97B	P/S ⓘ	1.75	EPS this Y ⓘ	5.86%	Inst Trans ⓘ	8.9%	Short Ratio ⓘ	3.74	Perf Half Y ⓘ	-15.69%
Sales ⓘ	29.14B	P/B ⓘ	2.91	EPS next 5Y ⓘ	9.23%	ROA ⓘ	3.11%	Short Interest ⓘ	36.30M	Perf YTD ⓘ	-7.74%
Book/sh ⓘ	13.32	P/C ⓘ	22.75	EPS past 3/5Y ⓘ	-	ROE ⓘ	8.5%	52W High ⓘ	-23.83% ($50.88)	Perf Year ⓘ	-
Cash/sh ⓘ	1.7	P/FCF ⓘ	48.71	Sales past 3/5Y ⓘ	9.85% -	ROIC ⓘ	4.06%	52W Low ⓘ	18.09% ($32.81)	Perf 3Y ⓘ	-
Dividend Est. ⓘ	$0.06 (0.15%)	EV/EBITDA ⓘ	21.89	EPS Y/Y TTM ⓘ	-22.07%	Gross Margin ⓘ	23.44%	Volatility(W/M) ⓘ	4.32% 4.2%	Perf 5Y ⓘ	-
Dividend TTM ⓘ	-	EV/Sales ⓘ	2.38	Sales Y/Y TTM ⓘ	12.07%	Oper. Margin ⓘ	7.39%	ATR (14) ⓘ	1.67	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	2.51	EPS Q/Q ⓘ	-62.12%	Profit Margin ⓘ	3.32%	RSI (14) ⓘ	48.86	Recom ⓘ	1.59
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	4.41	Sales Q/Q ⓘ	10.66%	SMA20 ⓘ	-3.35% ($40.09)	Beta ⓘ	-	Target Price ⓘ	$50.69
Payout ⓘ	-	Debt/Eq ⓘ	1.12	Earnings ⓘ	2026/8/5	SMA50 ⓘ	2.66% ($37.75)	Rel Volume ⓘ	0.51	Prev Close ⓘ	$37.63
Employees ⓘ	45000	LT Debt/Eq ⓘ	1.11	EPS/Sales Surpr. ⓘ	11.79% 2.64%	SMA200 ⓘ	-7.71% ($41.99)	Avg Volume(3M) ⓘ	9.71M	Price ⓘ	$38.75
IPO ⓘ	2025/12/17	Option/Short ⓘ	Yes/Yes			Trades ⓘ	31448	Volume ⓘ	4,996,910	Change ⓘ	2.98%

📊 Medline Inc (MDLN) Investment Analysis

What kind of company is Medline Inc?

메드라인(MDLN) 성장주

Healthcare · Medical Instruments & Supplies

Top 320 by Market Cap — Large-Cap

A global healthcare supply chain company operating in medical supplies, devices, and medical distribution businesses. Founded in the United States in 1966 and headquartered in Northfield, Illinois, it broadly supplies hospitals, nursing homes, and outpatient clinics with medical consumables and its own branded products.

Learn more about Medline Inc →

Market Cap

$50.9B

Approx. KRW 69.7 trillion

⚖️ 18% of Samsung Electronics

Market Cap Rank320

Employees45,000people

IPO2025/12/17

Current Price$38.75 ≈ 53,088원

NASD · USA

Key Events

⏰ Upcoming events

🔔 Earnings release D-9

8월 5일 (수) · 장 시작 전

예상 EPS $0.32

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 5월 6일 (수) · 장 시작 전 EPS +11.8% 매출 +2.6%

🔔 Earnings release 2026년 2월 25일 (수) · 장 시작 전

Is it profitable?

Financial health solid

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

7.4%

✓ 양호

My positionMid-range

Low range Average High range

Medical Instruments & Supplies Median 5.5% · Top 44%

💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수

Net Margin

Share of revenue left after taxes and interest are paid

3.3%

✓ 양호

My positionMid-range

Low range Average High range

Medical Instruments & Supplies Median -5.3% · Top 35%

💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

23.4%

✓ 부진

My positionBottom 25%

Low range Average High range

Medical Instruments & Supplies Median 48.6% · Bottom 22%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROE

Annual return earned on shareholders' equity (15%+ is strong)

8.5%

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 대형주 Median 11.9% · Bottom 39%

💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)

ROA

Annual earnings relative to total company assets

3.1%

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 대형주 Median 5.1% · Bottom 33%

💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수

ROIC

Return generated per dollar invested in the business

4.1%

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 대형주 Median 7.4% · Bottom 33%

💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

1.12

✓ Average

My positionMid-range

Low range Average High range

Medical Instruments & Supplies Median 0.26

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

4.41

✓ 양호

My positionMid-range

Low range Average High range

Medical Instruments & Supplies Median 2.34

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

2.51

✓ 양호

My positionMid-range

Low range Average High range

Medical Instruments & Supplies Median 1.97

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$50.69

현재가 대비 +30.8%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

예상 PER (Forward)

23.38배

💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인

PEG (성장 반영 밸류)

2.53

고평가

💡 PEG > 2 — 성장 대비 비싼 편

내년 EPS 예상 성장률

+9.4%

💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상

5년 EPS 예상 연평균

+9.2%

💡 장기 성장 전망. 15% 이상이면 고성장 기업

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Reliability

Beat estimates in 2 of the last 2 quarters

예상 상회

예상 부합

예상 하회

100%

상회 비율

+36.0%

평균 서프라이즈

2026.05.06

상회

실적 $0.33 · 예상 $0.29 +12.2%

2026.02.25

상회

실적 $0.38 · 예상 $0.24 +59.9%

💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Growth Concerns

Growth is lagging the industry average

🔮 How much will it grow? (analyst forecasts)

This Year's EPS Outlook

Projected EPS growth rate for this year

+5.9%

매우 부진

My positionBottom 5%

Low range Average High range

성장주 대형주 Median 15.4% · Bottom tier

Next Year's EPS Outlook

Projected EPS growth rate for next year (analyst consensus)

+9.4%

부진

My positionBottom 25%

Low range Average High range

성장주 대형주 Median 13.1% · Bottom 20%

5-Year EPS CAGR Outlook

Projected average annual EPS growth over the next 5 years

+9.2%

매우 부진

My positionBottom 5%

Low range Average High range

성장주 대형주 Median 14.9% · Bottom tier

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

+10.7%

평균

My positionMid-range

Low range Average High range

성장주 대형주 Median 11.2% · Bottom 47%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Returns by period

Current position within 52-week range

Low (-18.1%p) High (-23.8%p)

Current price is 18.1% above the 52-week low and 23.8% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-33.6%

Annualized volatility

43.2%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-24

Downtrend zone

Current price $38.75 below the midline ($40.09). Normal downward flow. Inside the Ichimoku cloud (neutral).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-07-24

Neutral zone — weak trend

MACD 0.012 · Signal 0.383 · Hist -0.371. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-24

Bearish zone

RSI 48.9 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 30.6.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average

Cheap on Vs. Earnings·Vs. Sales, In line with peers on Vs. Assets·Vs. Cash Flow

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Mid-range

🧾 Vs. Sales Cheap

💧 Vs. Cash Flow Mid-range

💵 Vs. Earnings

PER Price-to-Earnings Ratio

How expensive the price is vs. earnings — lower is cheaper

32.41x

✓ Cheap

My positionMid-range

Low range Average High range

Medical Instruments & Supplies median 35.22x · Around the industry average

💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)

💵 Vs. Earnings

Forward PER Forward Price-to-Earnings Ratio

PER using next year's estimated earnings — reflects growth

23.38x

✓ Fair

My positionMid-range

Low range Average High range

Medical Instruments & Supplies median 18.44x · Around the industry average

💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

2.91x

✓ Fair

My positionMid-range

Low range Average High range

Medical Instruments & Supplies median 2.71x · Around the industry average

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

1.75x

✓ Very cheap

My positionTop 25%

Low range Average High range

Medical Instruments & Supplies median 2.92x · Top 25% — relatively cheap within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

💧 Vs. Cash Flow

EV/EBITDA Enterprise Value Multiple

Total enterprise value ÷ operating cash earnings — a benchmark for M&A

21.89x

✓ Fair

My positionMid-range

Low range Average High range

Medical Instruments & Supplies median 14.76x · Around the industry average

💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)

💧 Vs. Cash Flow

P/FCF Price-to-Free-Cash-Flow Ratio

Price vs. actual cash generation — lower means more efficient

48.71x

✓ Fair

My positionMid-range

Low range Average High range

Medical Instruments & Supplies median 25.16x · Around the industry average

💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)

Analyst target price (reference)

$50.69 vs. current price +30.8%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Medical Instruments & Supplies

Who owns it?

Ownership flow shows some pressure

Insider net selling -37.5% · Institutional net buying +8.9% · Short interest moderate 6.7% · Short interest up +4.9pp over last 90d

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

-37.5%

Insiders large net selling

🏦 Institutions (funds & investors)

+8.9%

Institutions net buying

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 63.8%

Adequate institutional weight

Healthcare 대형주 Median 91.9%

🧑‍💼 Insiders 36.1%

Founder/management large holders (strong skin-in-the-game)

Healthcare 대형주 Median 0.8%

👤 Retail investors (estimated) 0.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

6.7%

Moderate

Healthcare 대형주 Median 3.6%

Past 90 days 📈 +4.9%p increase

Short interest days to cover

3.7 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 846.0M주

Float (tradable shares) 540.0M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding MDLN

ETFs with the highest weightings · 10 total shown

First Trust US Equity Opportunities ETF

5.28%

$1.6B

XHE

State Street SPDR S&P Health Care Equipment ETF

1.83%

$153M

FXH

First Trust Health Care AlphaDEX Fund

0.87%

$1.0B

FMAG

Fidelity Magellan ETF

0.58%

$245M

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당 지급 — 연 0.15%

배당보다 주가 성장에 가까운 비중

Dividend Yield

0.15%

Industry average 1.25%

Dividend Per Share

$0.06

Annualized

Payout Ratio

Share of net income paid as dividends

5-Year Growth

Annualized dividend growth

💰 내가 100만원 투자한다면

연간 배당금 (세후) 1,316원

5년 누적 (세후) 6,581원

* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 0% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
MDLN This Stock	$50.9B	32.4 ▼	2.9 ▼	8.5% ▲	0.15% ▼	+3.0%
LLY	$1.13T	43.0 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.9%
JNJ	$634.1B	30.5 ▼	7.5 ▼	25.74% ▲	2.04% ▲	+1.6%
ABBV	$458.2B	127.9 ▼	-	15221.82% ▲	2.65% ▲	+0.9%
UNH	$382.1B	27.1 ▼	3.9 ▼	12.49% ▲	2.15% ▲	-0.7%
MRK	$323.7B	36.9 ▼	7.1 ▼	18.97% ▲	2.49% ▲	+0.5%
Sector Avg	-	25.8	2.7	-48.83%	1.25%	-

FAQ

What kind of company is 메드라인(MDLN)?

메드라인(MDLN) belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is the market cap of MDLN?

The market cap of MDLN is approximately $50.9B, ranking 320 within its sector.

Does MDLN pay dividends?

MDLN has a dividend yield of approximately 0.15%, with an annual dividend of $0.06.

What is the P/E ratio of MDLN?

MDLN has a P/E ratio of approximately 32.4x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for MDLN?

MDLN has recorded a 52-week high of $50.88 and a low of $32.81.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.